Zhicheng Lin

发表

Monoamine transporters: vulnerable and vital doorkeepers.

J. Canales, S. B. Caine, Qing-Rong Liu, 2011, Progress in molecular biology and translational science.

The dopamine transporter gene SLC6A3: multidisease risks

N. Volkow, M. Reith, A. Galli, 2021, Molecular Psychiatry.

Identification of an intronic cis-acting element in the human dopamine transporter gene

N. Xiong, Zhicheng Lin, Ying Zhao, 2012, Molecular Biology Reports.

Dopamine Transporter Transmembrane Domain Polar Mutants: ΔG and ΔΔG Values Implicate Regions Important for Transporter Functions

George R. Uhl, Masanari Itokawa, M. Itokawa, 2000 .

Involvement of CB2 Receptors in the Neurobehavioral Effects of Catha Edulis (Vahl) Endl. (Khat) in Mice

Qing-Rong Liu, Zhicheng Lin, E. Engidawork, 2019, Molecules.

Endocannabinoid Receptor Genetics and Marijuana Use

G. Uhl, J. Gong, C. M. Leonard, 2005 .

Endocannabinoids and cannabinoid receptor genetics

G. Uhl, C. M. Leonard, Zhicheng Lin, 2002, Progress in Neurobiology.

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference

Z. Xi, Qing-Rong Liu, J. Egan, 2017, Scientific Reports.

Correction: Temporal Dissection of Rate Limiting Transcriptional Events Using Pol II ChIP and RNA Analysis of Adrenergic Stress Gene Activation

Harvard Medical School, Beilei Lei, G. Michelotti, 2015, PloS one.

Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations.

M. Itokawa, G. Uhl, Zhicheng Lin, 2002, Brain research. Molecular brain research.

SLC6A3 is a risk factor for Parkinson's disease: A meta-analysis of sixteen years’ studies

Zhicheng Lin, Desheng Zhai, Ying Zhao, 2014, Neuroscience Letters.

The correlation between DNA methylation and transcriptional expression of human dopamine transporter in cell lines

Yunlei Yang, Yuxin Yang, Zhicheng Lin, 2018, Neuroscience Letters.

Intragenic Transcriptional cis-Antagonism Across SLC6A3

H. Qing, N. Xiong, Xiaowu Chen, 2018, Molecular Neurobiology.

Autonomous Vascular Networks Synchronize GABA Neuron Migration in the Embryonic Forebrain

G. Szabó, Zhicheng Lin, A. Elkhal, 2013, Nature Communications.

Epistatic evidence for gender-dependant slow neurotransmission signalling in substance use disorders: PPP1R12B versus PPP1R1B

N. Volkow, G. Koob, H. Qing, 2020, EBioMedicine.

Genetic influences of dopamine transport gene on alcohol dependence: A pooled analysis of 13 studies with 2483 cases and 1753 controls

Mingqing Xu, Zhicheng Lin, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKA.

G. Uhl, Qing-Rong Liu, J. Troncoso, 2004, The Biochemical journal.

The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse.

G. Uhl, T. Drgon, Zhicheng Lin, 2004, Pharmacogenetics.

Dopamine Transporter (DAT) Inhibitors Alleviate Specific Parkinsonian Deficits in Monkeys: Association with DAT Occupancy in Vivo

B. Madras, A. Fischman, A. Bonab, 2006, Journal of Pharmacology and Experimental Therapeutics.

Presence of recombination hotspots throughout SLC6A3

H. Qing, N. Xiong, Juan Zhao, 2019, PloS one.

Cocaine Reduces the Neuronal Population While Upregulating Dopamine D2-Receptor-Expressing Neurons in Brain Reward Regions: Sex-Effects

N. Volkow, Juan Zhao, C. Du, 2021, Frontiers in Pharmacology.

Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia

D. Clair, J. Xuan, G. He, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Cannabinoid receptor genetics and behavior

G. Uhl, Zhicheng Lin, P. Zhang, 2002 .

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference

Z. Xi, Qing-Rong Liu, J. Egan, 2017, Scientific Reports.

Molecular neurobiological methods in marijuana-cannabinoid research.

G. Uhl, Qing-Rong Liu, B. Hope, 2006, Methods in molecular medicine.

The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins

I. Sora, G. Uhl, Zhicheng Lin, 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Common Human 5′ Dopamine Transporter (SLC6A3) Haplotypes Yield Varying Expression Levels In Vivo

Deborah C. Mash, George R. Uhl, Tomas Drgon, 2006, Cellular and Molecular Neurobiology.

Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities

G. Uhl, Zhicheng Lin, 2003, The Pharmacogenomics Journal.

Human dopamine transporter gene: differential regulation of 18-kb haplotypes.

H. Qing, N. Xiong, Zhicheng Lin, 2013, Pharmacogenomics.

Proline mutations induce negative‐dosage effects on uptake velocity of the dopamine transporter

G. Uhl, Zhicheng Lin, 2005, Journal of neurochemistry.

Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro

T. Spencer, B. Madras, G. Miller, 2006, Journal of Pharmacology and Experimental Therapeutics.

Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine‐abusing versus non‐abusing subjects

Jun Liu, M. Bannon, Zhicheng Lin, 2014, Addiction biology.

The Transcription Factor Orthodenticle Homeobox 2 Influences Axonal Projections and Vulnerability of Midbrain Dopaminergic Neurons.

E. Martin, J. Vance, A. Simeone, 2010 .

Phosphatidylinositol 3-Kinase, Protein Kinase C, and MEK1/2 Kinase Regulation of Dopamine Transporters (DAT) Require N-terminal DAT Phosphoacceptor Sites*

G. Uhl, J. Melgari, Zhicheng Lin, 2003, Journal of Biological Chemistry.

Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons

Sarah L. Withey, S. George, J. Bergman, 2019, iScience.

The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions.

G. Uhl, Zhicheng Lin, 2003, European journal of pharmacology.

Identification of HIVEP2 as a dopaminergic transcription factor related to substance use disorders in rats and humans

H. Qing, Chunnuan Chen, R. Bell, 2019, Translational Psychiatry.

Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism.

G. Uhl, Zhicheng Lin, 2002, Molecular pharmacology.

SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism.

G. Uhl, T. Drgon, Zhicheng Lin, 2005, Human molecular genetics.

Genetic influences of dopamine transport gene on alcohol dependence: A pooled analysis of 13 studies with 2483 cases and 1753 controls

Mingqing Xu, Zhicheng Lin, 2011, Progress in Neuro-psychopharmacology and Biological Psychiatry.

Intragenic Transcriptional cis-Antagonism Across SLC6A3

H. Qing, N. Xiong, Xiaowu Chen, 2018, Molecular Neurobiology.

The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons.

E. Martin, J. Vance, A. Simeone, 2010, Brain : a journal of neurology.

SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism.

G. Uhl, T. Drgon, Zhicheng Lin, 2005, Human molecular genetics.